Parker graduated with a B.S. in Chemistry in 2015 from the University of South Carolina. He then obtained his M.S. in Chemistry and Chemical Biology from Cornell University in 2017. In 2023, Parker completed his Ph.D. as an NSF Graduate Research Fellow (NSF GRFP) under Prof. Amy Kuceyeski in Computational Biology from Cornell University, where he used multimodal neuroimaging and network modeling and to understand the impacts of psychedelic drugs on human brain function - both acutely in healthy volunteers, and post-acutely in veterans with PTSD. In his first postdoc, also with Prof. Kuceyeski at Weill Cornell Medicine, he used similar approaches to understand the chronic effects of substance use in the brain. Here at PennLINC, Parker will be assessing the evidence base of the clinical psychedelic literature, while engaging in more neuroscience research of psychedelics, and assisting the neuroinformatics team on data release and software initiatives.